We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $303B
1-Year Est. Return 53.02%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
-0.55%
1 Year Est. Return
+53.02%
3 Year Est. Return
+141.18%
5 Year Est. Return
+166.47%
10 Year Est. Return
+608.47%
AUM
$169B
AUM Growth
+$3.15B
Cap. Flow
-$12.2B
Cap. Flow %
-7.19%
Top 10 Hldgs %
24.72%
Holding
6,611
New
422
Increased
2,034
Reduced
2,705
Closed
792

Sector Composition

Rank Sector Weight
1 Miscellaneous 55.8%
2 Technology 11.32%
3 Financials 6.52%
4 Consumer Discretionary 5.41%
5 Healthcare 5.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TKNO icon
5076
Alpha Teknova
TKNO
$400M
$22K ﹤0.01%
+885
New +$18.9K
XOS icon
5077
Xos
XOS
$37M
$22K ﹤0.01%
+159
New +$40.2K
ZYME icon
5078
Zymeworks
ZYME
$1.97B
$22K ﹤0.01%
732
-1,172
-62% -$39K
CSSE
5079
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
$22K ﹤0.01%
928
+381
+70% +$11K
AFIB
5080
DELISTED
Acutus Medical Inc
AFIB
$22K ﹤0.01%
2,455
+1,501
+157% +$19.7K
ONCR
5081
DELISTED
Oncorus, Inc.
ONCR
$22K ﹤0.01%
2,329
+1,357
+140% +$15.5K
CSLT
5082
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$22K ﹤0.01%
13,935
+8,251
+145% +$16.2K
AUTL
5083
Autolus Therapeutics
AUTL
$511M
$21K ﹤0.01%
3,199
-72
-2% -$455
CSD icon
5084
Invesco S&P Spin-Off ETF
CSD
$217M
$21K ﹤0.01%
337
-2,006
-86% -$130K
FCT
5085
DELISTED
First Trust Senior Floating Rate Income Fund II
FCT
$21K ﹤0.01%
1,701
+1,501
+751% +$18.6K
FLNT
5086
Fluent
FLNT
$112M
$21K ﹤0.01%
1,536
+1,177
+328% +$17.7K
HIBL icon
5087
Direxion Daily S&P 500 High Beta Bull 3X ETF
HIBL
$76.5M
$21K ﹤0.01%
340
-1,100
-76% -$69.5K
HPF
5088
John Hancock Preferred Income Fund II
HPF
$315M
$21K ﹤0.01%
973
+121
+14% +$2.67K
MMT
5089
Aberdeen Multi-Market Income Fund
MMT
$235M
$21K ﹤0.01%
3,238
-5,521
-63% -$35.2K
NATH icon
5090
Nathan's Famous
NATH
$401M
$21K ﹤0.01%
340
+205
+152% +$13.5K
ODC icon
5091
Oil-Dri
ODC
$1.27B
$21K ﹤0.01%
1,194
+634
+113% +$11.1K
RXI icon
5092
iShares Global Consumer Discretionary ETF
RXI
$246M
$21K ﹤0.01%
125
-230
-65% -$38.9K
SCO icon
5093
ProShares UltraShort Bloomberg Crude Oil
SCO
$877M
$21K ﹤0.01%
69
SPYV icon
5094
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.4B
$21K ﹤0.01%
542
-5,233
-91% -$209K
STK
5095
Columbia Seligman Premium Technology Growth Fund
STK
$928M
$21K ﹤0.01%
630
+230
+58% +$7.78K
TARS icon
5096
Tarsus Pharmaceuticals
TARS
$3.7B
$21K ﹤0.01%
962
+561
+140% +$13.9K
CYT
5097
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$21K ﹤0.01%
+1,222
New +$22.8K
ONCT
5098
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$21K ﹤0.01%
257
+152
+145% +$12.6K
TIG
5099
DELISTED
Trean Insurance Group, Inc. Common Stock
TIG
$21K ﹤0.01%
1,982
+1,143
+136% +$13.6K
CLSD
5100
DELISTED
Clearside Biomedical
CLSD
$20K ﹤0.01%
+227
New +$20K

Similar funds

Citigroup's Q3 2021 Portfolio in Review

As of Q3 2021, Citigroup held 6,611 positions worth $169B, up 1.9% from $166B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Citigroup withdrew a net $12.2B in Q3 2021, closing 792 positions and reducing 2,705 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $809M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 49% a quarter earlier, followed by Technology and Financials.

Against the trend, Citigroup opened a new position in Hennessy Capital Investment Corp. VI Unit worth $90.5M.

  • Citigroup's largest Q3 2021 buy was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
  • Citigroup added most to Invesco Dorsey Wright Momentum ETF in Q3 2021, an estimated $591M increase.
  • Citigroup's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.25B.
  • Citigroup fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $809M.
  • Citigroup's ten largest holdings make up 25% of its $169B portfolio in Q3 2021.
  • Citigroup opened 422 new positions and closed 792 in Q3 2021.
  • Citigroup's portfolio value rose 1.9% quarter-over-quarter to $169B.

Based on Citigroup's 13F filing for Q3 2021, filed 10 Nov 2021.